Literature DB >> 32375027

Systematic Analysis of Targets of Pumilio-Mediated mRNA Decay Reveals that PUM1 Repression by DNA Damage Activates Translesion Synthesis.

Toshimichi Yamada1, Naoto Imamachi2, Katsutoshi Imamura2, Kenzui Taniue2, Takeshi Kawamura2, Yutaka Suzuki3, Masami Nagahama1, Nobuyoshi Akimitsu4.   

Abstract

RNA-binding proteins (RBPs) play a pivotal role in gene expression by modulating the stability of transcripts. However, the identification of degradation target mRNAs of RBPs remains difficult. By the combined analysis of transcriptome-wide mRNA stabilities and the binding of mRNAs to human Pumilio 1 (PUM1), we identify 48 mRNAs that both bind to PUM1 and exhibit PUM1-dependent degradation. Analysis of changes in the abundance of PUM1 and its degradation target mRNAs in RNA-seq data indicate that DNA-damaging agents negatively regulate PUM1-mediated mRNA decay. Cells exposed to cisplatin have reduced PUM1 abundance and increased PCNA and UBE2A mRNAs encoding proteins involved in DNA damage tolerance by translesion synthesis (TLS). Cells overexpressing PUM1 exhibit impaired DNA synthesis and TLS and increased sensitivity to the cytotoxic effect of cisplatin. Thus, our method identifies target mRNAs of PUM1-mediated decay and reveals that cells respond to DNA damage by inhibiting PUM1-mediated mRNA decay to activate TLS.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRIC-seq; DNA damage; Pumilio; RIP-seq; RNA stability; RNA-binding proteins; RNA-seq; in silico screening; translesion synthesis

Mesh:

Substances:

Year:  2020        PMID: 32375027     DOI: 10.1016/j.celrep.2020.107542

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  6 in total

1.  Repression of PUM1-mediated mRNA decay activates translesion synthesis after DNA damage.

Authors:  Toshimichi Yamada; Xiaoning Sun; Nobuyoshi Akimitsu
Journal:  Mol Cell Oncol       Date:  2020-10-12

Review 2.  The Functions and Unique Features of LncRNAs in Cancer Development and Tumorigenesis.

Authors:  Kenzui Taniue; Nobuyoshi Akimitsu
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

Review 3.  DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target.

Authors:  Ashlynn Ai Li Ler; Michael P Carty
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

4.  Regulation of Parkinson's disease-associated genes by Pumilio proteins and microRNAs in SH-SY5Y neuronal cells.

Authors:  Lisa J Snoderly-Foster; Wendy M Olivas
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

5.  Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome.

Authors:  Isioma I I Enwerem; Nathan D Elrod; Chung-Te Chang; Ai Lin; Ping Ji; Jennifer A Bohn; Yevgen Levdansky; Eric J Wagner; Eugene Valkov; Aaron C Goldstrohm
Journal:  RNA       Date:  2021-01-04       Impact factor: 4.942

6.  Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancer.

Authors:  Quan Lin; Danli Xie; Liangliang Pan; Yongliang Lou; Mengru Shi
Journal:  Biosci Rep       Date:  2021-10-29       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.